Background Medical therapy of atrial fibrillation (AF) can be challenging in patients with
Brugada electrocardiograms (ECGs). The purpose of this study was to investigate the …

Aims The therapeutical management of atrial fibrillation (AF) in the setting of Brugada
syndrome (BS) might be challenging as many antiarrhythmic drugs (AADs) with sodium …

Background Pharmacological treatment of atrial fibrillation (AF) in the setting of Brugada
syndrome (BrS) is challenging. In addition, patients with BrS with an implantable …

Aims Pharmacological treatment of atrial fibrillation (AF) in the setting of Brugada syndrome
(BS) might be challenging as many antiarrhythmic drugs (AADs) with sodium channel …

Supraventricular arrhythmias are common in Brugada syndrome (BS), and notoriously
difficult to manage with medical therapy secondary to associated risks. Pulmonary vein …

Background: Ectopic atrial activity in the pulmonary veins (PV) and superior vena cava
(SVC) has been recently described as a possible trigger for atrial fibrillation (AF). However …

Background A high prevalence of atrial fibrillation/atrial flutter (AF/AFl) has been reported in
small series of Brugada patients, with discordant data. Objective The purpose of this study …

Background In patients with an implantable cardioverter-defibrillator (ICD) and Brugada
syndrome (BrS), the long-term efficacy of catheter ablation for preventing inappropriate …

Background: Circumferential pulmonary vein isolation (CPVI) is increasingly performed for
the treatment of symptomatic drug-refractory paroxysmal atrial fibrillation. Long-term data …

Background Epicardial ablation is occasionally limited by coronary artery (CA) injuries or
epicardial fat (EF). Objective The purpose of this study was to evaluate the anatomic …